Novotech Announces Expansion into Taiwan
Novotech today announced the opening of the Novotech Taiwan office as part of its ongoing Asian expansion.
Increasing demand for quality research has prompted the opening of a Novotech dedicated office to manage global and regional studies. The Taipei office will complement existing operations in India, South Korea, Thailand, Malaysia and Singapore.
Novotech CEO Alek Safarian said at Partnerships in Clinical Trials Phoenix, Arizona) that the first Taipei office employee was hired this month and five more will be in place by mid-year.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
